Not intended as a textbook of adverse drug reactions but rather as a way to elucidate the methods of investigating adverse drug reactions as well as other questions of drug effects. Section one gives an introduction to the field & presents basic scientific principles of clinical epidemiology. In this edition a chapter has been added on analogous basic principles of clinical pharmacology. A presentation of multiple different perspectives on clinical epidemiology can be found in the second section. Due to major new methodological developments in the field, sections three & four have had new chapters added & others removed. The first three sections will be of interest to the neophyte while sections two through four will appeal to those with some background who want a more in-depth view of the field.
What people are saying - Write a review
We haven't found any reviews in the usual places.
What is Pharmacoepidemiology?
A Public Health Perspective from Academia
A View from a Regulatory Agency
28 other sections not shown
ADRs adverse drug reactions adverse events adverse reactions analysis antibiotic approach assessment association automated Bendectin bias birth defects breast cancer case-control studies causality Chapter Clin Pharmacol cohort studies computerized confounding cost databases detect diagnoses disease dose drug effects drug exposure drug safety Drug Surveillance drug utilization efficacy Engl Epidemiol epidemiologic estimate estrogen evaluation example exposed follow-up gastrointestinal Health hospital identified important incidence increase individual inpatient investigators JAMA marketing measures Medicaid medical records ment meta-analysis methods monitoring myocardial infarction National NSAIDs occur oral contraceptives outcome outpatient patients phar pharma pharmaceutical pharmacoepidemiology pharmacoepidemiology research pharmacoepidemiology studies pharmacokinetic pharmacy physicians population postmarketing surveillance potential premarketing prescribing prescription drug problems RCTs recall relative risk risk factors sample Saskatchewan Shapiro specific spontaneous reporting system statistical Strom BL study design teratogenic therapeutic therapy tion toxic treatment vaccine validity variable